Holen Sie sich die Stockscreener-App
156.39
0.08%
-0.12
Handel nachbörslich:
156.39
Glaukos Corporation Aktie (GKOS) Neueste Nachrichten
Assenagon Asset Management S.A. Trims Stock Position in Glaukos Co. (NYSE:GKOS) - MarketBeat
Oak Ridge Investments LLC Makes New Investment in Glaukos Co. (NYSE:GKOS) - MarketBeat
Glaukos Co. (NYSE:GKOS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Personal Finance - Business Wire
Glaukos Shares Rise Amid Promising Trial Results - TipRanks
GKOS Stock Gains Following Positive Study Data on iDose Platform - MSN
(GKOS) Trading Signals - Stock Traders Daily
Glaukos reports sustained efficacy in iDose TR trials By Investing.com - Investing.com South Africa
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform - BioSpace
Glaukos reports sustained efficacy in iDose TR trials - Investing.com
Glaukos Highlights Advances in Glaucoma Treatments - TipRanks
Glaukos says iDose TR showed sustained substantial IOP reductions in Phase 3 - TipRanks
Glaukos iDose TR Shows Strong 36-Month Results with 70% Patient Control Rate in Glaucoma Trial - StockTitan
Thomas Burns: The 2-Decade Bet That’s Paying Off - Orange County Business Journal
Here's Why You Should Add Glaukos Stock to Your Portfolio Now - MSN
Harbor Capital Advisors Inc. Makes New Investment in Glaukos Co. (NYSE:GKOS) - MarketBeat
Glaukos Reaches 52-Week High: What's Driving the Stock's Rally? - MSN
Glaukos stock soars to all-time high of $153.72 By Investing.com - Investing.com Nigeria
Glaukos (NYSE:GKOS) Hits New 1-Year HighStill a Buy? - MarketBeat
Glaukos stock soars to all-time high of $153.72 - Investing.com
(GKOS) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Glaukos price target raised to $157 from $149 at BTIG - Yahoo Finance
What 11 Analyst Ratings Have To Say About Glaukos - Benzinga
Glaukos To Rally Around 17%? Here Are 6 Top Analyst Forecasts For Tuesday - Benzinga
Glaukos (NYSE:GKOS) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Stifel backs Glaukos shares with higher price target and positive long-term iDose outlook - Investing.com Canada
Glaukos Corporation Sees A Bright Future In Huntsville - Huntsville Business Journal
Franklin Resources Inc. Purchases 6,948 Shares of Glaukos Co. (NYSE:GKOS) - MarketBeat
Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA - MSN
GKOS (Glaukos) Change In Working Capital : $-36.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
(GKOS)Analyzing Glaukos's Short Interest - Benzinga
(GKOS) Trading Report - Stock Traders Daily
Are Investors Undervaluing Glaukos Corporation (NYSE:GKOS) By 50%? - Simply Wall St
Glaukos (NYSE:GKOS) Reaches New 1-Year HighTime to Buy? - MarketBeat
Pharmaceutical giant chooses to invest $82 million in Huntsville facility - MSN
Glaukos Co. (NYSE:GKOS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Glaukos president sells $498,715 in stock - Investing.com India
Glaukos director Gilbert H. Kliman sells shares worth $1.5 million - Investing.com India
Glaukos director Gilbert H. Kliman sells shares worth $1.5 million By Investing.com - Investing.com Australia
Glaukos president sells $498,715 in stock By Investing.com - Investing.com Australia
Glaukos Co. (NYSE:GKOS) Shares Sold by Principal Financial Group Inc. - MarketBeat
0.25%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):